We have located links that may give you full text access.
Journal Article
Research Support, Non-U.S. Gov't
Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs.
BMJ : British Medical Journal 2003 July 6
OBJECTIVE: To estimate the risk of acute hepatotoxicity associated with nimesulide compared with other non-steroidal anti-inflammatory drugs.
DESIGN: Retrospective cohort and nested case-control study.
SETTING: Umbria region, Italy.
PARTICIPANTS: 400 000 current, recent, and past users (almost 2 million prescriptions) of non-steroidal anti-inflammatory drugs between 1 January 1997 and 31 December 2001.
MAIN OUTCOME MEASURES: Admissions to hospital for acute non-viral hepatitis and incidence of all hepatopathies and liver injury among users of nimesulide and other non-steroidal anti-inflammatory drugs.
RESULTS: Current use of non-steroidal anti-inflammatory drugs was associated with a 1.4 (95% confidence interval 1.0 to 2.1) increased risk of hepatopathy compared with past use. In current users of nimesulide the rate ratio for all hepatopathies and more severe liver injury was 1.3 (0.7 to 2.3) and 1.9 (1.1 to 3.8), respectively.
CONCLUSION: The risk of liver injury in patients taking nimesulide and other non-steroidal anti-inflammatory drugs is small.
DESIGN: Retrospective cohort and nested case-control study.
SETTING: Umbria region, Italy.
PARTICIPANTS: 400 000 current, recent, and past users (almost 2 million prescriptions) of non-steroidal anti-inflammatory drugs between 1 January 1997 and 31 December 2001.
MAIN OUTCOME MEASURES: Admissions to hospital for acute non-viral hepatitis and incidence of all hepatopathies and liver injury among users of nimesulide and other non-steroidal anti-inflammatory drugs.
RESULTS: Current use of non-steroidal anti-inflammatory drugs was associated with a 1.4 (95% confidence interval 1.0 to 2.1) increased risk of hepatopathy compared with past use. In current users of nimesulide the rate ratio for all hepatopathies and more severe liver injury was 1.3 (0.7 to 2.3) and 1.9 (1.1 to 3.8), respectively.
CONCLUSION: The risk of liver injury in patients taking nimesulide and other non-steroidal anti-inflammatory drugs is small.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices 
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app